Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kimberly Venella"'
Autor:
Joseph H. Oved, Nora M. Gibson, Kimberly Venella, Caitlin W. Elgarten, Lisa Wray, Julia T. Warren, Timothy S. Olson
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Severe congenital neutropenia (SCN) is caused by germline mutations, most commonly in ELANE, impacting neutrophil maturation and leading to high risk of life-threatening infections. Most patients with ELANE-mutant SCN can achieve safe neutrophil coun
Externí odkaz:
https://doaj.org/article/6513bb6fcbd54929b6b72109d32eeff5
Publikováno v:
Frontiers in Pediatrics, Vol 10 (2022)
BackgroundCongenital amegakaryocytic thrombocytopenia (CAMT) is a rare platelet production disorder caused mainly by loss of function biallelic mutations in myeloproliferative leukemia virus oncogene (MPL), the gene encoding the thrombopoietin recept
Externí odkaz:
https://doaj.org/article/3d3d45b40fa948cb84d6402527339440
Autor:
Nora M. Gibson, Joseph H. Oved, Kimberly Venella, Caitlin W. Elgarten, Lisa Wray, Timothy S. Olson
Publikováno v:
Transplantation and Cellular Therapy. 29:S173-S174
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a766964926ac97a21cbf70deaedd5532
https://doi.org/10.1016/s2666-6367(23)00291-9
https://doi.org/10.1016/s2666-6367(23)00291-9
Autor:
Laura T. Smith, Kimberly Venella
Publikováno v:
Clinical Journal of Oncology Nursing. 21:29-34
Background Pediatric patients with relapsed and refractory acute lymphoblastic leukemia are more often being treated with chimeric antigen receptor (CAR) T-cell therapy. As with any new therapy, the management of this patient population has a unique
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8ddde10f9ce07a08129647f7958c944
https://doi.org/10.1188/17.cjon.s2.29-34
https://doi.org/10.1188/17.cjon.s2.29-34